Mike Polark
Stock Analyst at Baird
(2.28)
# 2,699
Out of 5,147 analysts
87
Total ratings
43.86%
Success rate
-0.15%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $133.75 | +49.53% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $64.51 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $47.51 | -1.07% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $86.47 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $97.66 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $12.63 | +58.35% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $70.60 | -15.01% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $246.61 | +41.92% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $23.28 | +24.57% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $256.26 | -29.76% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $98.44 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $387.46 | +4.53% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $503.51 | -0.10% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $116.35 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $122.06 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $73.43 | +64.78% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $25.30 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.25 | +53.85% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $175.35 | -5.90% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $76.85 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $14.58 | -10.84% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.08 | +414.71% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $252.35 | -0.93% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.51 | +2,747.68% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $133.75
Upside: +49.53%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $64.51
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $47.51
Upside: -1.07%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $86.47
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $97.66
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $12.63
Upside: +58.35%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $70.60
Upside: -15.01%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $246.61
Upside: +41.92%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $23.28
Upside: +24.57%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $256.26
Upside: -29.76%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $98.44
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $387.46
Upside: +4.53%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $503.51
Upside: -0.10%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $116.35
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $122.06
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $73.43
Upside: +64.78%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $25.30
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.25
Upside: +53.85%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $175.35
Upside: -5.90%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $76.85
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $14.58
Upside: -10.84%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.08
Upside: +414.71%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $252.35
Upside: -0.93%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.51
Upside: +2,747.68%